Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, December 1998, p. 3117-3122, Vol. 42, No. 12
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
OXA-16, a Further Extended-Spectrum Variant of
OXA-10
-Lactamase, from Two Pseudomonas
aeruginosa Isolates
Franck
Danel,1,*
Lucinda M. C.
Hall,1
Deniz
Gur,2 and
David M.
Livermore1,
Antibiotic Group, Department of Medical
Microbiology, St. Bartholomew's and the Royal London School of
Medicine and Dentistry, London, E1 2AD, United
Kingdom,1 and
Section of Infectious
Diseases, Department of Internal Medicine, Hacettepe University School
of Medicine, 06100 Ankara, Turkey2
Received 13 March 1998/Returned for modification 14 July
1998/Accepted 21 September 1998
Two extended-spectrum mutants of the class D
-lactamase OXA-10
(PSE-2) from Pseudomonas aeruginosa isolates obtained in
Ankara, Turkey, were described previously and were designated OXA-11
and -14. P. aeruginosa 906 and 961, isolated at the same
hospital, were highly resistant to ceftazidime (MIC
128 µg/ml) and produced a
-lactamase with a pI of 6.2. The MICs of
ceftriaxone, cefoperazone, cefsulodin, and cefepime were 4- to 16-fold
above the typical values for P. aeruginosa, whereas the
MICs of penicillins and cefotaxime were raised only marginally.
Ceftazidime MICs were not significantly reduced by clavulanate or
tazobactam at 4 µg/ml. Ceftazidime resistance did not transfer
conjugatively but was mobilized to P. aeruginosa PU21 by
plasmid pUZ8. Both isolates gave similar DNA restriction patterns,
suggesting that they were replicates; moreover, they yielded
identically sized BamHI fragments that hybridized with a
blaOXA-10 probe. DNA sequencing revealed that
both isolates had the same new
-lactamase, designated OXA-16, which
differed from OXA-10 in having threonine instead of alanine at position
124 and aspartate instead of glycine at position 157. The latter change
is also present in OXA-11 and -14 and seems critical to ceftazidime
resistance. Kinetic parameters showed that OXA-16 enzyme was very
active against penicillins, cephaloridine, cefotaxime, and ceftriaxone,
but hydrolysis of ceftazidime was not detected despite the ability of
the enzyme to confer resistance.
*
Corresponding author. Present address: F. Hoffmann-La
Roche Ltd., Pharmaceuticals Division, Pharma Research Preclinical
Infectious Disease, CH-4070 Basel, Switzerland. Phone: 41-61-6880537. Fax: 41-61-6882729. E-mail franck.danel{at}roche.com.

Present address: Antibiotic Reference Unit, Laboratory of Hospital
Infection, Central Public Health Laboratory, London NW9
5HT, United
Kingdom.
Antimicrobial Agents and Chemotherapy, December 1998, p. 3117-3122, Vol. 42, No. 12
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Strateva, T., Yordanov, D.
(2009). Pseudomonas aeruginosa - a phenomenon of bacterial resistance. J Med Microbiol
58: 1133-1148
[Abstract]
[Full Text]
-
Paterson, D. L., Bonomo, R. A.
(2005). Extended-Spectrum {beta}-Lactamases: a Clinical Update. Clin. Microbiol. Rev.
18: 657-686
[Abstract]
[Full Text]
-
Mushtaq, S., Ge, Y., Livermore, D. M.
(2004). Doripenem versus Pseudomonas aeruginosa In Vitro: Activity against Characterized Isolates, Mutants, and Transconjugants and Resistance Selection Potential. Antimicrob. Agents Chemother.
48: 3086-3092
[Abstract]
[Full Text]
-
Toleman, M. A., Rolston, K., Jones, R. N., Walsh, T. R.
(2003). Molecular and Biochemical Characterization of OXA-45, an Extended-Spectrum Class 2d' {beta}-Lactamase in Pseudomonas aeruginosa. Antimicrob. Agents Chemother.
47: 2859-2863
[Abstract]
[Full Text]
-
Niumsup, P., Wuthiekanun, V.
(2002). Cloning of the class D {beta}-lactamase gene from Burkholderia pseudomallei and studies on its expression in ceftazidime-susceptible and -resistant strains. J Antimicrob Chemother
50: 445-455
[Abstract]
[Full Text]
-
De Champs, C., Poirel, L., Bonnet, R., Sirot, D., Chanal, C., Sirot, J., Nordmann, P.
(2002). Prospective Survey of {beta}-Lactamases Produced by Ceftazidime- Resistant Pseudomonas aeruginosa Isolated in a French Hospital in 2000. Antimicrob. Agents Chemother.
46: 3031-3034
[Abstract]
[Full Text]
-
Bert, F., Branger, C., Lambert-Zechovsky, N.
(2002). Identification of PSE and OXA {beta}-lactamase genes in Pseudomonas aeruginosa using PCR-restriction fragment length polymorphism. J Antimicrob Chemother
50: 11-18
[Abstract]
[Full Text]
-
Bradford, P. A.
(2001). Extended-Spectrum {beta}-Lactamases in the 21st Century: Characterization, Epidemiology, and Detection of This Important Resistance Threat. Clin. Microbiol. Rev.
14: 933-951
[Abstract]
[Full Text]
-
Yau, Y. H., Ho, B., Tan, N. S., Ng, M. L., Ding, J. L.
(2001). High Therapeutic Index of Factor C Sushi Peptides: Potent Antimicrobials against Pseudomonas aeruginosa. Antimicrob. Agents Chemother.
45: 2820-2825
[Abstract]
[Full Text]
-
Petrella, S., Clermont, D., Casin, I., Jarlier, V., Sougakoff, W.
(2001). Novel Class A {beta}-Lactamase Sed-1 from Citrobacter sedlakii: Genetic Diversity of {beta}-Lactamases within the Citrobacter Genus. Antimicrob. Agents Chemother.
45: 2287-2298
[Abstract]
[Full Text]
-
Poirel, L., Girlich, D., Naas, T., Nordmann, P.
(2001). OXA-28, an Extended-Spectrum Variant of OXA-10 {beta}-Lactamase from Pseudomonas aeruginosa and Its Plasmid- and Integron-Located Gene. Antimicrob. Agents Chemother.
45: 447-453
[Abstract]
[Full Text]
-
Bou, G., Oliver, A., Martínez-Beltrán, J.
(2000). OXA-24, a Novel Class D beta -Lactamase with Carbapenemase Activity in an Acinetobacter baumannii Clinical Strain. Antimicrob. Agents Chemother.
44: 1556-1561
[Abstract]
[Full Text]
-
Danel, F., Hall, L. M. C., Duke, B., Gur, D., Livermore, D. M.
(1999). OXA-17, a Further Extended-Spectrum Variant of OXA-10 beta -Lactamase, Isolated from Pseudomonas aeruginosa. Antimicrob. Agents Chemother.
43: 1362-1366
[Abstract]
[Full Text]
-
Danel, F., Hall, L. M. C., Livermore, D. M.
(1999). Laboratory mutants of OXA-10 {beta}-lactamase giving ceftazidime resistance in Pseudomonas aeruginosa. J Antimicrob Chemother
43: 339-344
[Abstract]
[Full Text]